Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gluzman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Proceedings. Biological Sciences|April 22, 2020
Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theoryMark Gluzman, Jacob G Scott, Alexander Vladimirsky
Exploration of Targeted Anti-Tumor Therapy|April 4, 2025
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinomaIlya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko, et al.
Cancer Medicine|February 14, 2025
Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real-World, Ambispective RAVE-Bladder StudyIlya Tsimafeyeu, Yana Gridneva, Alexander Sultanbaev, et al.
BJU International|August 29, 2025
Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?Ruslan Zukov, Yana Gridneva, Yulia Anzhiganova, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Proceedings. Biological Sciences|April 22, 2020
Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theoryMark Gluzman, Jacob G Scott, Alexander Vladimirsky
Exploration of Targeted Anti-Tumor Therapy|April 4, 2025
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinomaIlya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko, et al.
Cancer Medicine|February 14, 2025
Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real-World, Ambispective RAVE-Bladder StudyIlya Tsimafeyeu, Yana Gridneva, Alexander Sultanbaev, et al.
BJU International|August 29, 2025
Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?Ruslan Zukov, Yana Gridneva, Yulia Anzhiganova, et al.
Pageof 1